Current trends with FOXP3 + regulatory T cell immunotherapy to contest autoimmunity and inflammation - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Immunotherapy Année : 2019

Current trends with FOXP3 + regulatory T cell immunotherapy to contest autoimmunity and inflammation

Dates et versions

inserm-02455416 , version 1 (26-01-2020)

Identifiants

Citer

Jamma Trinath, Jagadeesh Bayry. Current trends with FOXP3 + regulatory T cell immunotherapy to contest autoimmunity and inflammation. Immunotherapy, 2019, 11 (9), pp.755-758. ⟨10.2217/imt-2019-0069⟩. ⟨inserm-02455416⟩
45 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More